MeSH term
Frequency | Condition_Probility | Animals | 9 | 0.0 |
Humans | 16 | 0.0 |
Mice | 8 | 0.0 |
Neuroblastoma/*genetics | 2 | 2.0 |
Research Support, Non-U.S. Gov't | 17 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 6 | 0.0 |
Tumor Cells, Cultured | 3 | 0.0 |
Base Sequence | 2 | 0.0 |
Cell Line | 2 | 0.0 |
Receptor, EphB4 | 3 | 25.0 |
Receptor, EphB6 | 2 | 100.0 |
Receptors, Eph Family | 3 | 23.0 |
Lymphocyte Activation | 2 | 0.0 |
Comparative Study | 3 | 0.0 |
*Gene Expression Regulation, Neoplastic | 3 | 0.0 |
Neoplasm Staging | 2 | 0.0 |
Prognosis | 7 | 0.0 |
Receptor, EphB2 | 3 | 14.0 |
Child | 2 | 0.0 |
Ephrin-B3 | 3 | 60.0 |
Genes, myc/genetics | 2 | 2.0 |
Ephrin-B2 | 3 | 21.0 |
Membrane Proteins/metabolism | 2 | 0.0 |
Female | 3 | 0.0 |
Immunohistochemistry | 2 | 0.0 |
Tissue Distribution | 3 | 0.0 |
COS Cells | 2 | 0.0 |
Ligands | 5 | 0.0 |
RNA/biosynthesis | 2 | 2.0 |
Receptor Protein-Tyrosine Kinases/*biosynthesis | 2 | 3.0 |
Reverse Transcriptase Polymerase Chain Reaction | 3 | 0.0 |
Male | 2 | 0.0 |
Signal Transduction | 3 | 0.0 |
Cell Line, Tumor | 2 | 0.0 |
Up-Regulation | 2 | 0.0 |
In Vitro | 2 | 0.0 |